Company
Allegria Therapeutics AG
Incorporated
December 2023
Headquarter
Basel
Support
Therapeutics that modulate mast cell activity
Allegria Therapeutics is a Basel-based biopharma startup established in 2023 with a commitment to build a differentiated portfolio of therapeutic approaches around biological targets that modulate mast cells as drivers of allergy and inflammatory disease. We focus our efforts on sustainable innovation to address significant unmet medical need and drive long-term growth.
